Skip Navigation



Carcinogenesis Advance Access published online on October 21, 2004

Carcinogenesis, doi:10.1093/carcin/bgh300
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/1/249    most recent
bgh300v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhang, W.
Right arrow Articles by Grossman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, W.
Right arrow Articles by Grossman, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received August 6, 2004
Revised September 23, 2004
Accepted September 27, 2004

CARCINOGENESIS

UVB-induced apoptosis drives clonal expansion during skin tumor development

Wengeng Zhang 1, Adrianne N. Hanks 2, Kenneth Boucher 3, Scott R. Florell 4, Sarah M. Allen 2, April Alexander 5, Douglas E. Brash 1, and Douglas Grossman 6*

1 Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA
2 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
3 Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
4 Department of Dermatology, University of Utah, Salt Lake City, UT 84132, USA
5 Department of Dermatology, University of Utah, Salt Lake City, UT 84132, USA; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
6 Department of Dermatology, University of Utah, Salt Lake City, UT 84132, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA

* To whom correspondence should be addressed.
Douglas Grossman, E-mail: doug.grossman{at}hci.utah.edu


   Abstract

The mechanism by which a single mutant cell clonally expands is usually assumed to involve an additional mutation in a cell cycle regulatory gene. An alternative mechanism for driving clonal expansion is apoptosis, which might create vacant stem cell compartments that can be repopulated by mutant cells. This model predicts that in a mousse with reduced apoptosis capacity i) more mutated cells will appear initially but ii) these cells will expand into clones more slowly than in wild-type animals. To test this hypothesis for ultraviolet-B (UVB)-induced skin carcinogenesis, we examined UVB-induced p53-mutant clones and tumors in a transgenic (Tg) mouse (K14-Survivin) with skin-specific expression of the apoptosis inhibitor Survivin. To limit the effects of Survivin to apoptosis, without affecting epidermal proliferation or differentiation, we used Survivin expression levels and UVB doses that resulted in a 2-fold reduction in keratinocyte apoptosis. After 5 wks of chronic UVB irradiation, newly created p53-mutant keratinocyte clones (indicative of initial mutation frequency) were 1.4-fold more frequent in K14-Survivin mice (p=4x10-6). As predicted, this effect was reversed for clones growing by clonal expansion, which were rarer in Tg skin by 1.7-fold (p=.047). At 10 wks, large expanding Tg clones were rarer by a magnitude approaching the apoptosis differential (~2-fold, p=4x10-5). Survivin expression also retarded clonal expansion at later stages of tumor development. By 20 wks, 95% of animals carried tumors (primarily papillomas), which were 1.6-fold rarer in apoptosis-defective Tg mice (p=.03). By contrast, the rate of tumors attaining large size (≥3 mm, p=.048) and converting to carcinoma was increased ~2-fold in Tg mice. Thus Survivin-regulated apoptosis appears to suppress two stages that involve new mutations - initiation and malignant conversion - yet drives clonal expansion of existing p53-mutant cells.

Keywords: UVB; Survivin; apoptosis; carcinogenesis; transgenic.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. L. Chao, J. T. Eck, D. E. Brash, C. C. Maley, and E. G. Luebeck
Preneoplastic lesion growth driven by the death of adjacent normal stem cells
PNAS, September 30, 2008; 105(39): 15034 - 15039.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Charruyer, S. M. Bell, M. Kawano, S. Douangpanya, T.-Y. Yen, B. A. Macher, K. Kumagai, K. Hanada, W. M. Holleran, and Y. Uchida
Decreased Ceramide Transport Protein (CERT) Function Alters Sphingomyelin Production following UVB Irradiation
J. Biol. Chem., June 13, 2008; 283(24): 16682 - 16692.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. T. Black, J. P. Gray, M. P. Shakarjian, D. L. Laskin, D. E. Heck, and J. D. Laskin
Distinct effects of ultraviolet B light on antioxidant expression in undifferentiated and differentiated mouse keratinocytes
Carcinogenesis, January 1, 2008; 29(1): 219 - 225.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Thomas, T. Liu, M. A. Cotter, S. R. Florell, K. Robinette, A. N. Hanks, and D. Grossman
Melanocyte Expression of Survivin Promotes Development and Metastasis of UV-Induced Melanoma in HGF-Transgenic Mice
Cancer Res., June 1, 2007; 67(11): 5172 - 5178.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.